Skip to main content
SpringerLink
Log in

Chemoprevention of carcinoma prostate. A review

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose:Chemoprevention of prostate cancer is the administration of agents to prevent, inhibit, or delay progression of prostate cancer. Opportunities exist for testing various types of chemopreventive interventsion.Material and methods:The authors reviewed the relevant articles published in the last twenty years and studied the biology of the prostate cancer. An attempt is made to identify intermediate markers and surrogate endpoint markers. The various interventions and initial clinical trial results are described. End points for evaluation are mainly based on changes in PSA, changes of histological precursors, or time of onset of clinical disease.Results:Nutritional factors such as reduced fat intake, vitamin A, vitamin E, vitamin C, vitamin D, Lycopene and selenium may have a protective effect against prostate cancer.Conclusion:Numerous studies implicate dietary and nutritional factors in the onset and progression of prostate cancer. Hence, it is possible that bioactive compounds (anti-oxidants) like vits. A, C, D, E, minerals like selenium and carotenoids like lycopene can be a part of chemopreventive strategies for prostate cancer. Ongoing studies on nutrition and prostate cancer may bring the required evidence to support what is still only a hypothesis at present. However, absolute recommendation will have to await the results of long term prospective clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Albanes D, Heinonen OP, Huttunen JK et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the alpha-Tocopherol Bet-Carotene Cancer Prevention. Am J Clin Nutr 1995; 62 (Suppl): 1427S.

    Google Scholar 

  2. Alberts SR, Blute ML. Chemoprevention for prostatic carcinoma: The role of flutamide in patients with prostatic intraepithelial neoplasia. Urology 2001; 57 (4 Suppl 1): 188–190.

    Google Scholar 

  3. Ashish M Kamat, Donald L Lamm. Chemoprevention of urological cancer. J Urol 1999; 161: 1748–1760.

    Google Scholar 

  4. Benedict WF, Jones PA. Inhibition of transformation and oncologic progression by ascorbic acid: A possible role in chemoprevention. In: Arnot MS, van Eys J, Wang YM, eds, Molecular Interrelations of Nutrition and Cancer. New York: Raven Press, 1982: 351.

    Google Scholar 

  5. Boone CW, Kelloff GJ. Biomarker end-points in cancer chemoprevention trials. IARC Sci Publ 1997; 142: 273–280.

    Google Scholar 

  6. Boone CW, Bacus JW, Bacus JV et al. Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials. Proc Soc Exp Biol Med 1997; 216(2): 151–165.

    Google Scholar 

  7. Bosland MC. Use of animal models in defining efficacy of chemoprevention agents against prostate cancer. Eur Urol 1999; 35(5–6): 459–463.

    Google Scholar 

  8. Bostwick DG. Prostatic intraepithelial neoplasia is a risk factor for cancer. Semin Urol Oncol 1999; 17(4): 187–198.

    Google Scholar 

  9. Bostwick DG, Montironi R, Sesterhenn IA. Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group/consensus report. Scand J Urol Nephrol Suppl 2000; 205: 3–10.

    Google Scholar 

  10. Brooks JD, Weinstein M, Lin X et al. CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 1998; 7.

  11. Diaz GD, Paraskeva C, Thomas MG et al. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy. Cancer Res 2000; 60(8): 2304–2312.

    Google Scholar 

  12. Eilchholzer M, Stahelin HB, Gey KF et al. Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 1996; 66: 145.

    Google Scholar 

  13. Gupta S, Ahmad N, Mohan RR et al. Prostate cancer chemo-prevention by green tea: In vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase. Cancer Res 1999; 59(9): 2115–2120.

    Google Scholar 

  14. Gupta S, Ahmad N, Marengo SR et al. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAM mice. Cancer Res 2000; 60(18): 5125–5133.

    Google Scholar 

  15. Homma Y, Kaneko M, Kondo Y et al. Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143. J Natl Cancer Inst 1997; 89(11): 803–807.

    Google Scholar 

  16. Karmali RA. Eicosonoids in neoplasia. Prev Med 1987; 16: 493.

    Google Scholar 

  17. Khafif A, Schantz SP, al-Rawi M et al. Green tea regulates cell cycle progression in oral leukoplakia. Head Neck 1998; 20(6): 528–534.

    Google Scholar 

  18. van der Kwast TH. Intermediate biomarkers for chemoprevention of prostate cancer. IARC Sci Publ 2001; 154: 199–205.

    Google Scholar 

  19. Lew EA, Garfinkel. Variations in mortality by weight among 750,000 men and women. J Chron Dis 1979; 32: 563.

    Google Scholar 

  20. Lokshin A, Zhang H, Mayotte J et al. Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines. Anticancer Res 1999; 19(6B): 5251–5254.

    Google Scholar 

  21. Lopaczynski W, Hruszkewycz AM, Lieberman R. Prepro-statectomy: A clinical model to study stromal-epithelial interactions. Urology 2001; 57 (4 Suppl 1): 194–199.

    Google Scholar 

  22. Marmag C, Menon M, Balaji KC et al. Effects of vitamin C on the prostate cancer cells in vitro: Effect on cell number, viability, and DNA synthesis. Prostate 1997; 32: 188.

    Google Scholar 

  23. Marshall JR. High-grade prostatic intraepithelial neoplasia as an exposure biomarker for prostate cancer chemoprevention research. IARC Sci Publ 2001; 154: 191–198.

    Google Scholar 

  24. Miller GJ, Stapleton GE, Hedlund TE, Moffat KA. Vitamin D receptor expression 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines. Clin Cancer Res 1995; 1(9): 997–1003.

    Google Scholar 

  25. Niles RM. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer. Nutrition 2000; 16(11–12): 1084–1089.

    Google Scholar 

  26. Nomura AM, Klonel LN, Hankin JH, Youshizava CN. Dietary factors in cancer of the lower urinary tract. Int J Cancer 1991; 48: 199.

    Google Scholar 

  27. Rao KV, Johnson WD, Bosland MC et al. Chemoprevention of rat prostate carcinogenesis by early and delayed administration of dehydroepiandrosterone. Cancer Res 1999; 59(13): 3084–3089.

    Google Scholar 

  28. Rose DP. Dietary fatty acids and prevention of hormone responsive cancer. Proc Soc Exp Boil Med 1997; 216: 224.

    Google Scholar 

  29. Rose DP, Boyer AP, Wyner EI. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer 1986; 58: 2363.

    Google Scholar 

  30. Sakr WA, Partin AW. Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia. Urology 2001; 57 (4 Suppl 1): 115–120.

    Google Scholar 

  31. Schwartz GG, Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer (Hypothesis)? Anticancer Res 1990; 10: 1307.

    Google Scholar 

  32. Schwartz GG, Wang MH, Zang M et al. Alpha,25-Dihydroxyvitamin D (calciferol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomark Prev 1997; 6: 727.

    Google Scholar 

  33. Skowronski RJ, Peehl DM, Feldman D. Vitamin and prostate cancer: 1,25-dihydrovitamin D3 receptors and actions in human prostate cancer lines. Endocrinology 1993; 132: 152.

    Google Scholar 

  34. Slawin K, Kadmon D, Park SH et al. Dietary fenrethinide, a synthetic retinoid, decreases the tumor incidence and tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res 1993; 53: 4461.

    Google Scholar 

  35. Sun SY, Yue P, Mao L et al. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells. Clin Cancer Res 2000; 6(4): 1563–1573.

    Google Scholar 

  36. The alpha-Tocopherol Bet-Carotene Cancer Prevention Study. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994; 330: 1029.

    Google Scholar 

  37. Webber MM, Waghray A. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Clin Cancer Res 1995; 1(7): 755–761.

    Google Scholar 

  38. Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications. Prostate 1997; 30(2): 136–142.

    Google Scholar 

  39. Webber MM, Quader ST, Kelinman HK et al. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Prostate 2001; 47(1): 1–13.

    Google Scholar 

  40. Willet WC, Polk BF, Morris JS et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983; 2: 130.

    Google Scholar 

  41. Xie W, Wong YC, Tsao SW. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat. Prostate 2000; 44(1): 31–39.

    Google Scholar 

  42. Zhu W, Smith A, Young CY. A nonsteroidal anti-inflammatory drug, flufenamic acid, inhibits the expression of the androgen receptor in LNCaP cells. Endocrinology 1999; 140(11): 5451–5454.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, All India Institute of Medical Sciences, New Delhi, 110029, India

    M.S. Ansari, N.P. Gupta & A.K. Hemal

Authors
  1. M.S. Ansari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N.P. Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A.K. Hemal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M.S. Ansari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ansari, M., Gupta, N. & Hemal, A. Chemoprevention of carcinoma prostate. A review. Int Urol Nephrol 34, 207–214 (2002). https://doi.org/10.1023/A:1023297725004

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023297725004

Keywords

Search

Navigation